Vimarsana
Biggest News Aggregation in the World

Page 49 - Mc Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mc Services Today - Breaking & Trending Today

Carbios Doubles Its Number of Granted Patents in Two Years for Its Proprietary Enzymatic Technologies - Vimarsana News

Carbios Doubles Its Number of Granted Patents in Two Years for Its Proprietary Enzymatic Technologies

At end 2022, Carbios has 336 titles worldwide divided into 53 patent families for its innovation in enzymatic recycling of PET plastics and fibers, and its PLA biodegradation technology Carbios'

Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes - Vimarsana News

Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes

Exceeded target enrollment with 110 patients randomized across 28 clinical sites in Europe, the United States and AustraliaEfficacy proof-of-concept data from IMPACT is expected in Q1 2024. Following

EQS-News: Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes - Vimarsana News

EQS-News: Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes

EQS-News: Imcyse SA / Key word(s): Study Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes 01.03.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Imcyse Announces Completion of Enrollment in Phase 2 IMPA...

EQS-News: MC Services AG: MC Services to support BIO-Europe Spring 2023 in Basel as media partner - Vimarsana News

EQS-News: MC Services AG: MC Services to support BIO-Europe Spring 2023 in Basel as media partner

EQS-News: MC Services AG / Key word(s): Conference/Merger MC Services to support BIO-Europe Spring 2023 in Basel as media partner 01.03.2023 / 10:00 CET/CEST The issuer is solely

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Posting of Circular and Notice of General Meeting - Vimarsana News

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Posting of Circular and Notice of General Meeting

Investegate announcements from Destiny Pharma PLC, Posting of Circular and Notice of General Meeting